End-of-day quote
Other stock markets
|
||
- EUR | - |
10/05 | Laboratorio Reig Jofre, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
13/03 | Transcript : Laboratorio Reig Jofre, S.A., 2023 Earnings Call, Mar 13, 2024 |
Sales 2024 * | 35Cr 38Cr 3.16TCr | Sales 2025 * | 38Cr 41Cr 3.43TCr | Capitalization | 23Cr 25Cr 2.09TCr |
---|---|---|---|---|---|
Net income 2024 * | 1.1Cr 1.19Cr 100Cr | Net income 2025 * | 1.4Cr 1.52Cr 126.72Cr | EV / Sales 2024 * | 0.78 x |
Net Debt 2024 * | 3.95Cr 4.28Cr 357.52Cr | Net Debt 2025 * | 3.33Cr 3.61Cr 301.4Cr | EV / Sales 2025 * | 0.7 x |
P/E ratio 2024 * |
20.9
x | P/E ratio 2025 * |
16.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 21.21% |
Latest transcript on Laboratorio Reig Jofre SA
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 01/06/01 | |
Carmen Esclapés
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/01 |
Chief Operating Officer | 52 | 01/03/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 01/06/01 | |
Director/Board Member | - | 31/14/31 | |
Director/Board Member | - | 31/14/31 |
1st Jan change | Capi. | |
---|---|---|
+40.73% | 74TCr | |
+32.83% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
-5.52% | 21TCr | |
+6.17% | 16TCr | |
-0.45% | 16TCr |